Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
teratocarcinoma
MeSH D018243 - teratocarcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009373:
Germ cell and embryonal neoplasms
17 Companies
1 Drug
$
Success rate
D018243:
Teratocarcinoma
7 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Bleomycin
Cipla
Bleomycin
Bristol Myers Squibb
Bleomycin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use
